Making the Most of Medical Treatment
Page Highlights
-
Treatment for bipolar disorder is long term
-
Choose a doctor you like
-
Be an informed patient
Getting treatment for bipolar disorder is not a “once and done” thing. You will
need to see a doctor for a long period of time—perhaps for the rest of your
life. Below are some questions that may help you decide on the right doctor for
you.
Ask yourself these questions about the doctor:
-
Do you feel comfortable when you are with this person?
-
Do you respect this person’s knowledge?
-
Do you trust this person’s judgment?
-
Do you believe this person will do his or her best to help you get well?
-
Does this person seem to listen to your concerns?
-
Does this person try to answer your questions in a way you understand?
-
Is the office staff helpful when you make an appointment, ask a question, or
need to contact your provider?
When you like your doctor, it may make communication easier and help you stick
to your treatment plan.
Be an informed patient
Being an informed patient will help you on your way to managing bipolar
disorder.1 Learn from your doctor about what you can do to help your
treatment work. By working together, you will have a better chance of getting
the full benefits of treatment.
Here are some ideas:
-
Be on time and show up for all medical appointments
-
Do your best to follow your doctor’s advice—this may include things like taking
medicine as prescribed, getting regular sleep, and keeping a
Mood Diary1
-
Be honest about things that are bothering you
-
Let your doctor know if you notice mood changes
-
Tell your doctor if you are thinking about or stop taking a prescribed medicine
-
Ask questions. Choose questions you may wish to ask your doctor from our
Customized Discussion Guide
When a Loved One Has Bipolar Disorder

The information on this Web site should not take the place of talking with your
doctor or health care professional about how to manage and treat bipolar
disorder. If you have any questions about your condition, or if you would like
more information about SEROQUEL, talk to your doctor or pharmacist. Only you
and your doctor can decide if SEROQUEL is right for you.
Important Safety Information About SEROQUEL 
This is not a complete summary of safety information. Please discuss the full
Prescribing Information with your health care provider.
SEROQUEL is approved for depressive episodes and acute manic episodes in bipolar
disorder; long-term maintenance treatment of bipolar disorder in combination
with lithium or divalproex; and schizophrenia.
Elderly patients with dementia-related psychosis (having lost touch with
reality due to confusion and memory loss) treated with this type of medicine
are at an increased risk of death, compared to placebo (sugar pill). SEROQUEL
is not approved for treating these patients.
Antidepressants have increased the risk of suicidal thoughts and actions in
some children, teenagers, and young adults. Patients of all ages starting
treatment should be watched closely for worsening of depression, suicidal
thoughts or actions, unusual changes in behavior, agitation, and irritability.
Families and caregivers should watch patients daily and report these symptoms
immediately to the physician. SEROQUEL is not approved for patients under the
age of 18 years.
-
High blood sugar and diabetes have been reported with SEROQUEL and medicines
like it. If you have diabetes or risk factors such as obesity or a family
history of diabetes, ask your doctor about checking your blood sugar before
starting SEROQUEL and regularly throughout treatment. If you develop symptoms
of high blood sugar or diabetes, such as excessive thirst or hunger, increased
urination, or weakness, contact your doctor. Complications from diabetes can be
serious and even life threatening
-
A rare, but potentially fatal, side effect reported with SEROQUEL and medicines
like it is neuroleptic malignant syndrome (NMS). Tell your doctor if you have
very high fever; rigid muscles; shaking; confusion; sweating; changes in pulse,
heart rate, or blood pressure; or muscle pain and weakness because treatment
should be stopped if you have NMS
-
Another serious side effect reported with SEROQUEL and medicines like it is
tardive dyskinesia (TD)—uncontrollable movements of the face, tongue, or other
parts of the body. TD may become permanent, and the risk of TD is believed to
increase as the length of time on and the amount of these medications increase.
While TD can develop in patients taking low doses for short periods, this is
much less common. There is no known treatment for TD, but it may go away
partially or completely if treatment is stopped
-
Before starting treatment, tell your doctor if you have high cholesterol or
have a history of, or are at risk for, seizures or a low white blood cell (WBC)
count. An eye exam for cataracts is recommended at the beginning of treatment
and every 6 months thereafter. Suicidal thoughts or actions may occur in
bipolar disorder and schizophrenia; tell your doctor if you have thoughts about
death or suicide. During treatment, tell your doctor if you feel dizzy or
lightheaded upon standing. Since drowsiness has been reported with SEROQUEL,
you should not participate in activities such as driving or operating machinery
until you know that you can do so safely. Avoid drinking alcohol while taking
SEROQUEL because SEROQUEL increases the effects of alcohol. Avoid becoming
overheated or dehydrated while taking SEROQUEL
-
Common side effects: The most common side effects are dry mouth, sedation,
drowsiness, dizziness, constipation, weakness, abdominal pain, sudden drop in
blood pressure upon standing, sore throat, weight gain, sluggishness, high
blood sugar, nasal congestion, abnormal liver tests, and upset stomach
Talk to your doctor about prescription SEROQUEL.
Click here for full Prescribing Information, including Boxed Warnings.
You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.FDA.gov/medwatch
or call 1-800-FDA-1088.
REFERENCES:
-
Keck PE, Perlis RH, Otto MW, Carpenter D, Ross R, Docherty JP. The Expert
Consensus Guideline Series: Treatment of Bipolar Disorder 2004. A Postgraduate
Medicine Special Report. The McGraw-Hill Companies, Inc.; December
2004.